4CPS-039 Effectiveness of erenumab and galcanezumab in the treatment of migraine
Autor: | MA Carvajal-Sanchez, MD Najera-Perez, P Pacheco-Lopez, J Ibañez-Caturla, L Fructuoso-Gonzalez, P Torrano-Belmonte, JA Gutierrez-Sanchez, M Hernandez-Sanchez, A Bolufer-Perez, J Plaza-Aniorte, J Leon-Villar |
---|---|
Rok vydání: | 2022 |
Zdroj: | Section 4: Clinical pharmacy services. |
DOI: | 10.1136/ejhpharm-2022-eahp.84 |
Databáze: | OpenAIRE |
Externí odkaz: |